3PEA International, Inc. (OTCBB:TPNL)(OTCQB:TPNL),
a vertically integrated provider of innovative prepaid card programs and
processing services for corporate, consumer and government applications,
today announced that 3PEA and Haemonetics Corporation (NYSE:HAE)
have entered into an agreement whereby 3PEA International will integrate
its PaySign® Connect prepaid debit card solution with Haemonetics’ Donor
Management System (“DMS”). The integration will allow users of the
Haemonetics DMS to use the PaySign Connect payment solution for the
plasma industry. This partnership will bring together the best of both
worlds, the industry leading Haemonetics Donor Management System and
3PEA’s PaySign® Connect, an intuitive, easy-to-use, fully tokenized
payment system tailored to the unique requirements of the plasma
collection industry.
“We are excited to partner with Haemonetics to integrate The PaySign
Connect payment solution with their Donor Management System,” explained
Mark Newcomer, Chairman and CEO, 3PEA International. “We are confident
that the combination of Haemonetics’ DMS and the PaySign Connect payment
solution will be welcomed by the industry as the solution of choice for
their donor payment and management needs.”
“We are continually striving to improve and expand our offerings to our
plasma customers.” commented Pete Allen, President, Global Plasma for
Haemonetics. Tony Joy, Director, Plasma Software Sales, added “Working
with 3PEA to integrate its PaySign® Connect prepaid debit card solution
with Haemonetics’ DMS is another example of providing options that
enable our customers to further improve the efficiencies of their
operations. We’re looking forward to a successful relationship with 3PEA
as they increase their presence in the plasma donation payments space.”
About 3PEA International
3PEA International (OTCBB:TPNL) is an experienced and trusted prepaid
debit card payment solutions provider as well as an integrated payment
processor that has millions of prepaid debit cards in its portfolio.
Through its PaySign brand, 3PEA designs and develops payment solutions,
prepaid card programs, and customized payment services. 3PEA manages
programs for many of the world’s largest pharmaceutical manufacturers
with copay assistance products designed to maximize new patient
acquisition, retention and adherence. 3PEA’s corporate incentive prepaid
cards are changing the way corporations reward, motivate and engage
their current and potential customers, employees and agents. 3PEA’s
customizable prepaid solutions offer significant cost savings while
improving brand recognition and customer loyalty. 3PEA’s customers
include healthcare companies, major pharmaceutical companies and source
plasma providers, large multinationals, prestigious universities and
social media companies. PaySign is a registered trademark of
3PEA Technologies, Inc. in the United States and other countries. For
more information visit us at www.3pea.com
or follow us on LinkedIn,
Twitter
and Facebook.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to
providing innovative blood management solutions for our customers.
Together, our devices and consumables, information technology platforms,
and consulting services deliver a suite of business solutions to help
our customers improve patient care and reduce the cost of healthcare for
blood collectors, hospitals, and patients around the world. Our
technologies address important medical markets: blood and plasma
component collection, the surgical suite, and hospital transfusion
services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
Forward-Looking Statements
Certain statements in this news release may contain forward-looking
information within the meaning of Rule 175 under the Securities Act of
1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are
subject to the safe harbor created by those rules. All statements, other
than statements of fact, included in this release, including, without
limitation, statements regarding potential future plans and objectives
of the companies, are forward-looking statements that involve risks and
uncertainties. There is no assurance that such statements will prove to
be accurate, and actual results and future events could differ
materially. 3PEA undertakes no obligation to publicly update or revise
any statements in this release, whether as a result of new information,
future events, or otherwise.
Copyright Business Wire 2014